Topic: Translational Institute

Community Corner: A Q&A with digital trial expert Lauren Ariniello

Scripps Research study links sleep variability with sleep apnea and hypertension

How consumers’ digital activity trackers could enable personalized health screening and early intervention for cardiovascular health and beyond.

Eric Topol among U.S. News & World Report’s Best Leaders of 2025

Scripps Research scientists launch new digital clinical trial to test repurposed drug for long COVID symptom relief

Study will investigate whether a GIP/GLP-1 dual receptor agonist, currently approved for type 2 diabetes, obesity and obstructive sleep apnea, can reduce symptoms of long COVID.

Advancing targeted cancer treatments—in the lab and the clinic

AI model detects hidden diabetes risk by reading glucose spikes

Scripps Research scientists reveal how wearable sensors and artificial intelligence could transform the way we detect and manage pre-diabetes.

Kristian Andersen elected to Norwegian National Academy of Science and Letters

The science of longer, healthier lives

How close are we to a future where aging is no longer a barrier to vitality? Scripps Research executive vice president and professor Eric Topol discussed the themes of his new book on longevity. Drawing on the latest breakthroughs, he explored how innovations in artificial intelligence and drug discovery are combating chronic diseases like cancer, diabetes and neurodegeneration. Topol revealed how these advances are not only extending lifespans but also improving health at every stage of life.

Genomic data shows widespread mpox transmission in West Africa prior to 2022 global outbreak

Researchers show that mpox circulated among humans in Nigeria for eight years before the international outbreak, highlighting the need for improved surveillance.

Eric Topol authors book on the science of healthy aging

Latest book by Scripps Research executive vice president guides readers through medical breakthroughs that are primed to extend healthspan